Oct 15 (Reuters) - ADVICENNE SA ADVIC.PA :
* ADVICENNE RECEIVES HEALTH CANADA CLEARANCE TO EXTEND ITS PIVOTAL PHASE III TRIAL OF ADV7103 IN CANADA
* RECEIVED A NO OBJECTION LETTER TO EXTEND ITS ARENA-2 PIVOTAL PHASE III TRIAL FOR TREATMENT OF DISTAL RENAL TUBULAR ACIDOSIS (DRTA) IN CANADA